OpenURL Connection Search

Select item for more details and to access through your institution.

Photochemical pathogen inactivation of human serum enables its large-scale application in clinical cell transplantation.
Published in:
2010
By:
- Ståhle, M.;
- Carlsson, B.;
- Le Blanc, K.;
- Korsgren, O.;
- Knutson, F.
Publication type:
Letter
Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation.
Published in:
Stem Cells, 2012, v. 30, n. 7, p. 1575, doi. 10.1002/stem.1118
By:
- von Bahr, L.;
- Batsis, I.;
- Moll, G.;
- Hägg, M.;
- Szakos, A.;
- Sundberg, B.;
- Uzunel, M.;
- Ringden, O.;
- Le Blanc, K.
Publication type:
Article
Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells.
Published in:
Scandinavian Journal of Immunology, 2007, v. 65, n. 4, p. 336, doi. 10.1111/j.1365-3083.2007.01905.x
By:
- Rasmusson, I.;
- Le Blanc, K.;
- Sundberg, B.;
- Ringdén, O.
Publication type:
Article
Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin-2 Receptor) and CD38 on Phytohaemagglutinin-Activated Lymphocytes.
Published in:
Scandinavian Journal of Immunology, 2004, v. 60, n. 3, p. 307, doi. 10.1111/j.0300-9475.2004.01483.x
By:
- Le Blanc, K.;
- Rasmusson, I.;
- Götherström, C.;
- Seidel, C.;
- Sundberg, B.;
- Sundin, M.;
- Rosendahl, K.;
- Tammik, C.;
- Ringden, O.
Publication type:
Article
Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex.
Published in:
Scandinavian Journal of Immunology, 2003, v. 57, n. 1, p. 11, doi. 10.1046/j.1365-3083.2003.01176.x
By:
- Le Blanc, K.;
- Tammik, L.;
- Sundberg, B.;
- Haynesworth, S. E.;
- Ringdén, O.
Publication type:
Article
Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection.
Published in:
2006
By:
- Hertegård S;
- Cedervall J;
- Svensson B;
- Forsberg K;
- Maurer FHJ;
- Vidovska D;
- Olivius P;
- Ährlund-Richter L;
- Le Blanc K
Publication type:
Journal Article
Immunomodulation by mesenchymal stem cells and clinical experience.
Published in:
Journal of Internal Medicine, 2007, v. 262, n. 5, p. 509, doi. 10.1111/j.1365-2796.2007.01844.x
By:
- Le Blanc, K.;
- Ringdén, O.
Publication type:
Article
Quantitative chromogenic immunohistochemical image analysis in cellprofiler software.
Published in:
Cytometry. Part A, 2018, v. 93, n. 10, p. 1051, doi. 10.1002/cyto.a.23575
By:
- Tollemar, V.;
- Tudzarovski, N.;
- Boberg, E.;
- Törnqvist Andrén, A.;
- Al‐Adili, A.;
- Le Blanc, K.;
- Garming Legert, K.;
- Bottai, M.;
- Warfvinge, G.;
- Sugars, R.V.
Publication type:
Article
OP27.07: Intrauterine transfusion (IUT) of mesenchymal stem cells in two fetuses with fractures: follow-up to 3 and 4 years of age.
Published in:
Ultrasound in Obstetrics & Gynecology, 2010, v. 36, n. S1, p. 132, doi. 10.1002/uog.8182
By:
- Yamamoto, M.;
- Conget, P.;
- Anguita, T.;
- Allers, C.;
- Testart, E.;
- Castillo, S.;
- Gothestrom, C.;
- Le Blanc, K.;
- Crain, C.;
- Insunza, A.
Publication type:
Article
Immunotherapy prospects for acute myeloid leukaemia.
Published in:
Clinical & Experimental Immunology, 2010, v. 161, n. 2, p. 223, doi. 10.1111/j.1365-2249.2010.04197.x
By:
- Barrett, A. J.;
- Le Blanc, K.
Publication type:
Article
Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 9, p. 1217, doi. 10.1038/bmt.2015.123
By:
- von Bahr, L;
- Blennow, O;
- Alm, J;
- Björklund, A;
- Malmberg, K-J;
- Mougiakakos, D;
- Le Blanc, A;
- Oefner, P J;
- Labopin, M;
- Ljungman, P;
- Le Blanc, K
Publication type:
Article
Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation.
Published in:
Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 200, doi. 10.1038/bmt.2010.87
By:
- Bernardo, M. E.;
- Ball, L. M.;
- Cometa, A. M.;
- Roelofs, H.;
- Zecca, M.;
- Avanzini, M. A.;
- Bertaina, A.;
- Vinti, L.;
- Lankester, A.;
- Maccario, R.;
- Ringden, O.;
- Le Blanc, K.;
- Egeler, R. M.;
- Fibbe, W. E.;
- Locatelli, F.
Publication type:
Article
A new cell therapy registry coordinated by the European Group for Blood and Marrow Transplantation (EBMT).
Published in:
2008
By:
- Le Blanc, K.;
- Fibbe, W.
Publication type:
Letter
Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
Published in:
2006
By:
- Ringdén, O.;
- Svenberg, P.;
- Le Blanc, K.;
- Mattsson, J.;
- Remberger, M.
Publication type:
Letter
Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.
Published in:
Bone Marrow Transplantation, 2006, v. 37, n. 11, p. 1051, doi. 10.1038/sj.bmt.1705368
By:
- Sundin, M.;
- Örvell, C.;
- Rasmusson, I.;
- Sundberg, B.;
- Ringdén, O.;
- Le Blanc, K.
Publication type:
Article
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells.
Published in:
2004
By:
- Götherström, C;
- Ringdén, O;
- Westgren, M;
- Tammik, C;
- Le Blanc, K
Publication type:
Correction Notice
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells.
Published in:
Bone Marrow Transplantation, 2003, v. 32, n. 3, p. 265
By:
- Gotherstrom, C;
- Ringden, O;
- Westgren, M;
- Tammik, C;
- Le Blanc, K
Publication type:
Article
Immunosuppressive CD14(+)HLA-DR(low/neg) IDO(+) myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Published in:
2013
By:
- Mougiakakos D;
- Jitschin R;
- von Bahr L;
- Poschke I;
- Gary R;
- Sundberg B;
- Gerbitz A;
- Ljungman P;
- Le Blanc K
Publication type:
Journal Article
Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Published in:
Leukemia (08876924), 2013, v. 27, n. 2, p. 377, doi. 10.1038/leu.2012.215
By:
- Mougiakakos, D;
- Jitschin, R;
- von Bahr, L;
- Poschke, I;
- Gary, R;
- Sundberg, B;
- Gerbitz, A;
- Ljungman, P;
- Le Blanc, K
Publication type:
Article
Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon.
Published in:
Leukemia (08876924), 2007, v. 21, n. 11, p. 2271, doi. 10.1038/sj.leu.2404833
By:
- Ringdén, O.;
- Uzunel, M.;
- Sundberg, B.;
- Lönnies, L.;
- Nava, S.;
- Gustafsson, J.;
- Henningsohn, L.;
- Le Blanc, K.
Publication type:
Article
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.
Published in:
Leukemia (08876924), 2007, v. 21, n. 8, p. 1733, doi. 10.1038/sj.leu.2404777
By:
- Le Blanc, K.;
- Samuelsson, H.;
- Gustafsson, B.;
- Remberger, M.;
- Sundberg, B.;
- Arvidson, J.;
- Ljungman, P.;
- Lönnies, H.;
- Nava, S.;
- Ringdén, O.
Publication type:
Article

Found: 21

Photochemical pathogen inactivation of human serum enables its large-scale application in clinical cell transplantation.

Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation.

Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells.

Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin-2 Receptor) and CD38 on Phytohaemagglutinin-Activated Lymphocytes.

Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex.

Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection.

Immunomodulation by mesenchymal stem cells and clinical experience.

Quantitative chromogenic immunohistochemical image analysis in cellprofiler software.

OP27.07: Intrauterine transfusion (IUT) of mesenchymal stem cells in two fetuses with fractures: follow-up to 3 and 4 years of age.

Immunotherapy prospects for acute myeloid leukaemia.

Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation.

Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation.

A new cell therapy registry coordinated by the European Group for Blood and Marrow Transplantation (EBMT).

Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.

Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.

Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells.

Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells.

Immunosuppressive CD14(+)HLA-DR(low/neg) IDO(+) myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.

Immunosuppressive CD14<sup>+</sup>HLA-DR<sup>low/neg</sup> IDO<sup>+</sup> myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.

Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon.

Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.